News
Heart attack deaths have plummeted in recent years — but other types of cardiovascular disease still pose a major threat.. A new study by the American Heart Association (AHA) found that overall ...
The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.
References: US FDA accepts supplemental New Drug Application under Priority Review for new indication for Kerendia® (finerenone) in patients with heart failure with left ventricular ejection ...
Heart failure with preserved ejection fraction is noted for symptoms of heart failure, LVEF of at least 50%, and cardiac or structural abnormalities. Treatment includes diuretics and SGLT2 inhibitors.
The effort involved more than 100 hospitals across the U.S. and built on the Association's Get With The Guidelines ® - Heart Failure program. The study included data from more than 43,000 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results